Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors.
Chernov V, Rybina A, Zelchan R, Medvedeva A, Bragina O, Lushnikova N, Doroshenko A, Usynin E, Tashireva L, Vtorushin S, Abouzayed A, Rinne SS, Sörensen J, Tolmachev V, Orlova A. Chernov V, et al. Cancers (Basel). 2023 Mar 7;15(6):1631. doi: 10.3390/cancers15061631. Cancers (Basel). 2023. PMID: 36980517 Free PMC article.
Digoxin is a selective modifier increasing platinum drug anticancer activity.
Bogush TA, Chernov VY, Dudko EA, Shprakh ZS, Bogush EA, Polotsky BE, Tjulandin SA, Davydov MI. Bogush TA, et al. Among authors: chernov vy. Dokl Biochem Biophys. 2016 May;468(1):220-3. doi: 10.1134/S1607672916030170. Epub 2016 Jul 15. Dokl Biochem Biophys. 2016. PMID: 27417726
393 results